Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H Balance Sheet
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class H's total assets for Q4 2025 were ¥16.63B, a decrease of -2.89% from the previous quarter. HK:9989 total liabilities were ¥4.55B for the fiscal quarter, a -3.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.